Search Results 691-700 of 12906 for Acute angle-closure glaucoma

1. Expanded Access Study For The Treatment Of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel - Mayo Clinic

   The goal of this study is to provide access to brexucabtagene autoleucel for patients diagnosed with a disease approved for treatment with brexucabtagene ...

2. Dose Escalation Study Investigating The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics Of ASP2215 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia - Mayo Clinic

   ... treatment-refractory acute myeloid leukemia (AML). This study will also determine the pharmacokinetic (PK) parameters of ASP2215. Participation eligibility.

3. Neurosciences Clinical Trials - Medical Professionals

   ... acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) ...

4. (QuANTUM-R): An Open-label Study Of Quizartinib Monotherapy Vs. Salvage Chemotherapy In Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive - Mayo Clinic

   (QuANTUM-R): An Open-label Study Of Quizartinib Monotherapy Vs. Salvage Chemotherapy In Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive. Print ...

5. Tricyclic antidepressants and tetracyclic antidepressants - Mayo Clinic

   For example, if you have narrow-angle glaucoma, an enlarged prostate, heart ... Stopping treatment with tricyclic antidepressants. Tricyclic antidepressants aren' ...

6. A Study To Investigate Mepolizumab In The Treatment Of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

   The key outcomes in the study focus on evaluation of clinical remission, defined as Birmingham Vasculitis Activity Score (BVAS)=0 with a corticosteroid dose of ...

7. Avacincaptad pegol (intraocular route) - Side effects & uses - Mayo Clinic

   Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much. Send a Message · Find a ...

8. https://www.mayoclinic.org/procedure_concepts.xml

9. Michael P. Fautsch, Ph.D. - Doctors and Medical Staff - Mayo Clinic

   2013. Program Committee. Molecular Mechanisms in GlaucomaInternational Society of Eye Research ; 2012. Co-chairperson of the 8th Annual ARVO/Pfizer Conference ...

10. A Comparison Study To Cross-validate The Linear Analogue Self-Assessment (LASA), Patient-Reported Outcomes Measurement Information System (PROMIS), And Patient-reported Outcomes Version Of The Common Terminology Criteria For Adverse Events (PRO-CTCAE) In Assessing Cancer Patient Well-being - Mayo Clinic

    By condition, treatment or drug name. Search tips. A Comparison ... treatment (chemotherapy, targeted agents ... Closed for enrollment. More information ...